FUSED HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAS SIGNALLING

Among others, the present invention provides fused heterocyclic compounds of Formula (I) or tautomers, stereoisomer, or pharmaceutically acceptable salts thereof. These compounds and compositions containing them are useful in the treatment of cancers and other disorders associated with RAS dysfuncti...

Full description

Saved in:
Bibliographic Details
Main Authors YANG, Hongjian, BAO, Jianming, MA, Weiping, SU, Jing, CAO, Yexing, HO, Kan, QUAN, Weiguo, ZHANG, Xuxiang, GAO, Yingduo, SUN, Yongkui, ZHANG, Jing
Format Patent
LanguageEnglish
Published 08.08.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Among others, the present invention provides fused heterocyclic compounds of Formula (I) or tautomers, stereoisomer, or pharmaceutically acceptable salts thereof. These compounds and compositions containing them are useful in the treatment of cancers and other disorders associated with RAS dysfunction in a subject.
Bibliography:Application Number: AU20230209542